Systemic therapy provides substantial disease control in metastatic colorectal cancer (mCRC), yet liver metastases often determine prognosis; real-world evidence for using conversion-intent definitive liver-directed therapy (DLDT) as consolidation after first-... ...

请注册登录后继续浏览